|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.3 USD | +3.12% |
|
-10.60% | -8.51% |
| May. 21 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
| May. 09 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Savara Inc. announced that Badrul Chowdhury, M.D., Ph.D., has resigned from his role as Chief Medical Officer, effective September 9, 2022.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.51% | 576M | |
| +8.63% | 115B | |
| +13.17% | 107B | |
| -12.76% | 22.31B | |
| -3.99% | 21.6B | |
| -7.19% | 18.23B | |
| -39.93% | 17.62B | |
| +6.67% | 14.26B | |
| +33.90% | 12.37B | |
| -28.60% | 8.28B |
SAVARA INC. 